Crestline Management, LP
- SEC CIK
- 0001536054
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 3
- 0 vs. Q1 2025
- Portfolio value
- $62.6M
- −$672.8K (−1.1%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNLIDenali Therapeutics Inc. | COM | 3,860,732 | $54.0M | 86.3% | −300,000−7.2% | Reduced | History |
| SANASana Biotechnology, Inc. | COM | 2,420,937 | $6.61M | 10.6% | −370,000−13.3% | Reduced | History |
| EGHT8X8 Inc | COM | 990,580 | $1.94M | 3.1% | 00.0% | Unchanged | History |